{
  "main_header": {
    "sid": 286243,
    "name": "Parnax Lab",
    "stock_name": "Parnax Lab",
    "full_name": "Parnax Lab Ltd",
    "name_url": "stocks-analysis/parnax-lab",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "135.50",
    "chg": 1.9,
    "chgp": "1.42%",
    "dir": 1,
    "prev_price": "133.60",
    "mcapval": "154.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 506128,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 49,
    "indexname": "",
    "isin": "INE383L01019",
    "curr_date": "Apr 02",
    "curr_time": "",
    "bse_nse_vol": "3.59 k",
    "exc_status": "Active",
    "traded_date": "Apr 02, 2026",
    "traded_date_str": "2026 04 02",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://uat-researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/parnax-lab-286243-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [],
    "total": 248,
    "sid": "286243",
    "stock_news_url": "https://uat-researchintel.adityabirlamoney.com/news/parnax-lab-286243"
  },
  "announcements": [
    {
      "caption": "Closure of Trading Window",
      "datetime": "27-Mar-2026",
      "details": "The Trading Window for dealing in securities will be closed for all the Insiders Designated Persons and their Immediate Relatives w.e.f. 01st April 2026 and shall open 48 hours after the Audited Financial Results for the Quarter and Year ended March 30 2026 become generally available to he public.",
      "source": "BSE"
    },
    {
      "caption": "Financial Results For The Quarter Ended December 31 2025.",
      "datetime": "13-Feb-2026",
      "details": "Financial Results for the Quarter Ended December 31 2025.",
      "source": "BSE"
    },
    {
      "caption": "Financial Results For The Quarter Ended December 31 2025.",
      "datetime": "13-Feb-2026",
      "details": "Financial Results for the Quarter Ended December 31 2025.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

No Recent News for the Company

View All News